Corrigendum to Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC
Berger T, Brochet B, Brambilla L, et al. (2019). Effectiveness of delayed-release dimethyl fumarate on patient-reported outcomes and clinical measures in patients with relapsing–remitting multiple sclerosis in a real-world clinical setting: PROTEC. Multiple Sclerosis Journal—Experimental, Translational and Clinical, 5(4), 1–11. Original DOI: 10.1177/2055217319887191
On page 5, the characteristic mentioned in the 11th row of the table 1 is incorrect. It is mentioned as:
Time since most recent pre-study relapse, mean (SD), y
The correct characteristic should be:
Time since most recent pre-study relapse, mean (SD), mo